Hilltop Bio
PrivateLast Round
Series A
Mar 31, 2025
Est. Valuation
$22M
Total Funding Raised
$11.05M
Company Overview
Hilltop Bio operates in Healthcare & Life Sciences and is based in Norwood, Massachusetts. Its latest recorded funding round was a Series A round in March 2025.
Hilltop Bio is a veterinary biotechnology company that develops and provides regenerative therapies for joint health, soft tissue repair, and ophthalmology in horses and dogs.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Hilltop Bio Comparables
Compare Hilltop Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| AniCell Biotech | 84% | |
| eQcell Inc. | 81% | |
| CIMA Animal Health | 80% |
For institutional investors. Book with your work email.
Hilltop Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Mar 31, 2025 | ||||
| Strategic | Jan 23, 2025 | ||||
| Seed | Mar 30, 2023 | ||||
| Series A | Mar 10, 2022 | ||||
| Seed | Jul 1, 2019 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Hilltop Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Ag Startup Engine | Seed, Series A |
| Cherrystone Angel Group | Seed, Series A, Strategic |
| Launchpad Venture Group | Series A, Strategic, Seed |
| Frontier Angels | Seed |
| RevUp Capital | Debt |
| TiE ScaleUp | Series A |
| Band of Angels | Series A |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 24, 2024
Grew 25% QoQ, from 12 to 15 employees.
- Mar 17, 2024
Grew 33% QoQ from 12 to 16 employees.
For institutional investors. Book with your work email.
Hilltop Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Hilltop Bio's valuation, stock price, and market status.
Is Hilltop Bio a public or private company?
Hilltop Bio is a private company.
What is the current stock price of Hilltop Bio?
Hilltop Bio is a private company, so its shares have no public market price. Caplight tracks Hilltop Bio's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Hilltop Bio worth (valuation)?
Hilltop Bio's valuation is estimated at $22.0M based on funding round data.
Can I buy Hilltop Bio stock?
Hilltop Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Hilltop Bio's last funding round?
Hilltop Bio's most recent funding round was Series A on March 31, 2025.
Who are the main investors in Hilltop Bio?
Key investors in Hilltop Bio include Launchpad Venture Group, RevUp Capital.
Will Hilltop Bio IPO soon?
No public IPO plans have been announced for Hilltop Bio.
How can I track Hilltop Bio secondary market activity?
Caplight tracks bids, offers, and trades in Hilltop Bio's shares on secondary markets.